New Yorkers seeking the updated COVID-19 vaccine at CVS will need a prescription, raising concerns as federal officials adjust recommendations. What does this mean for you and your family?
A new study shows a troubling trend in ADHD treatment among preschoolers, revealing that a significant number are prescribed medication too quickly, often within 30 days of diagnosis. Experts advocate for behavioral interventions first.
CVS has announced major changes to COVID vaccine availability, offering shots in 34 states and requiring prescriptions in 13 others, leaving many Americans confused amid a new variant surge.
Eli Lilly announces a dramatic price increase for its diabetes medication Mounjaro in the UK, raising the monthly cost from £122 to £330. This change affects private buyers but not NHS prescriptions. Learn more about the implications!
A new study reveals alarming links between frequent gabapentin prescriptions for chronic low back pain and increased risks of dementia and mild cognitive impairment, especially in younger adults. Learn why monitoring is essential.
A pharmacy error nearly led to tragedy for a 9-year-old boy when he was mistakenly given a potent opioid instead of his ADHD medication. His family shares their alarming experience and urges caution.
Elon Musk has publicly denied recent allegations from the New York Times about his alleged extensive use of ketamine, clarifying that he only tried it once for mental health reasons.
The White House is set to fix errors in Secretary Kennedy's 'Make America Healthy Again' report, which faced scrutiny for citing studies that don’t exist. Despite controversies, the report aims to transform public health policy.
In a surprising move, Novo Nordisk CEO Lars Fruergaard Jorgensen steps down as the company faces significant market challenges and competition from Eli Lilly's Zepbound. With share prices plummeting, the board seeks new leadership to navigate the turbulent landscape.
Pharma faces a daunting challenge as Trump takes bold steps to cut drug prices. With RFK Jr. praising the move, is bipartisanship on the horizon or will the industry fight back?
